These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 22628425)
41. Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancer. Callejón-Leblic B; García-Barrera T; Pereira-Vega A; Gómez-Ariza JL J Pharm Biomed Anal; 2019 Jan; 163():122-129. PubMed ID: 30292984 [TBL] [Abstract][Full Text] [Related]
42. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction. Zhao LK; Zhao YB; Yu PC; Zhang PX Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481 [TBL] [Abstract][Full Text] [Related]
43. Experimental and Study Design Considerations for Uncovering Oncometabolites. Haznadar M; Mathé EA Methods Mol Biol; 2017; 1513():37-47. PubMed ID: 27807829 [TBL] [Abstract][Full Text] [Related]
44. Exploring serum metabolic markers for the discrimination of ccRCC from renal angiomyolipoma by metabolomics. Xiang M; Du F; Dai J; Chen L; Geng R; Huang H; Xie B Biomark Med; 2020 Jun; 14(8):675-682. PubMed ID: 32613842 [No Abstract] [Full Text] [Related]
45. A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine. Zhang T; Watson DG Analyst; 2015 May; 140(9):2907-15. PubMed ID: 25756251 [TBL] [Abstract][Full Text] [Related]
46. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. Manna SK; Patterson AD; Yang Q; Krausz KW; Idle JR; Fornace AJ; Gonzalez FJ J Proteome Res; 2011 Sep; 10(9):4120-33. PubMed ID: 21749142 [TBL] [Abstract][Full Text] [Related]
48. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study. Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504 [TBL] [Abstract][Full Text] [Related]
49. Imaging the clear cell renal cell carcinoma proteome. Morgan TM; Seeley EH; Fadare O; Caprioli RM; Clark PE J Urol; 2013 Mar; 189(3):1097-103. PubMed ID: 23009866 [TBL] [Abstract][Full Text] [Related]
50. Integrated plasma and liver gas chromatography mass spectrometry and liquid chromatography mass spectrometry metabolomics to reveal physiological functions of sodium taurocholate cotransporting polypeptide (NTCP) with an Ntcp knockout mouse model. Zhang Q; He Z; Liu Z; Gong L J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122531. PubMed ID: 33545502 [TBL] [Abstract][Full Text] [Related]
51. A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models. Beaudry P; Campbell M; Dang NH; Wen J; Blote K; Weljie AM Pediatr Blood Cancer; 2016 Feb; 63(2):214-20. PubMed ID: 26481088 [TBL] [Abstract][Full Text] [Related]
52. The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools. Trezzi JP; Vlassis N; Hiller K Adv Exp Med Biol; 2015; 867():41-57. PubMed ID: 26530359 [TBL] [Abstract][Full Text] [Related]
54. Metabolomic and elemental profiling of human tissue in kidney cancer. Nizioł J; Copié V; Tripet BP; Nogueira LB; Nogueira KOPC; Ossoliński K; Arendowski A; Ruman T Metabolomics; 2021 Mar; 17(3):30. PubMed ID: 33661419 [TBL] [Abstract][Full Text] [Related]
55. Twins labeling-liquid chromatography/mass spectrometry based metabolomics for absolute quantification of tryptophan and its key metabolites. Guo H; Jiao Y; Wang X; Lu T; Zhang Z; Xu F J Chromatogr A; 2017 Jun; 1504():83-90. PubMed ID: 28506496 [TBL] [Abstract][Full Text] [Related]
56. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry. Zeng Y; Lin Y; Li L; Li Y; Zhang X; Wang M; Chen Y; Luo L; Lu B; Xie Z; Liao Q J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():133-143. PubMed ID: 30807966 [TBL] [Abstract][Full Text] [Related]
57. Lactation-related metabolic mechanism investigated based on mammary gland metabolomics and 4 biofluids' metabolomics relationships in dairy cows. Sun HZ; Shi K; Wu XH; Xue MY; Wei ZH; Liu JX; Liu HY BMC Genomics; 2017 Dec; 18(1):936. PubMed ID: 29197344 [TBL] [Abstract][Full Text] [Related]
58. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry. Fang H; Zhang AH; Sun H; Yu JB; Wang L; Wang XJ J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():112-120. PubMed ID: 30743140 [TBL] [Abstract][Full Text] [Related]
59. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography. Lopes AS; Cruz EC; Sussulini A; Klassen A Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177 [TBL] [Abstract][Full Text] [Related]
60. Metabolome analysis for discovering biomarkers of gastroenterological cancer. Suzuki M; Nishiumi S; Matsubara A; Azuma T; Yoshida M J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():59-69. PubMed ID: 24636738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]